Rezolute (RZLT) Cash from Operations (2010 - 2026)
Rezolute's (RZLT) quarterly Cash from Operations came in at 13689000.0 in Q1 2026, up 21.33% year-on-year from 11282677.28 in Q1 2025, and up 32.8% quarter-over-quarter from 20370000.0 in Q4 2025.
Rezolute (RZLT) Cash from Operations (2010 - 2026) Analysis & Trends
Rezolute has disclosed Cash from Operations across 17 years of filings, most recently posting 13689000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 13689000.0, up 21.33% year-over-year; the trailing twelve-month figure through Mar 2026 was 73509000.0 (down 12.05% YoY), and the FY2025 annual result was 69100000.0, down 20.45% from the prior year.
- Cash from Operations came in at 13689000.0 for Q1 2026 at Rezolute, up from 20370000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 7493000.0 in Q4 2022 to a low of 22020000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 13968000.0 (2022), against an average of 14618588.24.
- Across the five-year window, Cash from Operations tumbled 158.81% in 2022 and grew 21.33% in 2026, its largest moves.
- Rezolute's Cash from Operations stood at 7493000.0 in 2022, then plunged by 73.76% to 13020000.0 in 2023, then slipped by 4.96% to 13666000.0 in 2024, then sank by 49.06% to 20370000.0 in 2025, then soared by 32.8% to 13689000.0 in 2026.
- The last three Cash from Operations figures came in at 13689000.0 (Q1 2026), 20370000.0 (Q4 2025), and 17430000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | -13.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.69 Mn |
| Mar 31, 2026 | -13.69 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Sep 30, 2025 | -17.43 Mn |
| Sep 30, 2025 | -17.43 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Dec 31, 2023 | -13.02 Mn |
| Dec 31, 2023 | -13.02 Mn |